Herpes zoster ophthalmicus treated with cytarabine.
D000328:Adult; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D004487:Edema / Q000188:drug therapy / Q000473:pathology; D004890:Erythema / Q000188:drug therapy / Q000473:pathology; D006563:Herpes Zoster Ophthalmicus / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
D003561:Cytarabine; D011241:Prednisone; D008775:Methylprednisolone